ICU Medical, Inc. Common Stock (ICUI) Technical Analysis
$152.65
Market is closed - opens 7 PM, 21 Sep 2026
Insights
- ICU Medical Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for ICU Medical Inc. stock suggests that it is a good time to buy
- Based on analysis of the Moving Averages technical indicator, ICU Medical Inc. stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for ICU Medical Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 27.22 | Buy |
Stochastic | 5.26, 2.81 | Buy |
Ultimate Oscillator | 25.53 | Buy |
Stochastic Relative Strength Index | 0.66, 2.02 | Neutral |
Moving Average Convergence Divergence | -5.07, -3.05 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 157.79 | Sell |
20 | 166.76 | Sell |
50 | 168.03 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 158.25 | Sell |
20 | 163.32 | Sell |
50 | 163.56 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 158.2 | Neutral |
20 | 166.76 | Sell |
50 | 169.25 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 152.1 | Sell |
20 | 157.34 | Sell |
50 | 170.54 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 151.21 | Buy |
20 | 150.94 | Sell |
50 | 166.25 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 161.17 |
Resistance L2 | 159.47 |
Resistance L1 | 156.19 |
Pivot Point | 154.49 |
Support L1 | 151.21 |
Support L2 | 149.51 |
Support L3 | 146.23 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.